May 2016 Newsletter
IASLC-LCFA Joint Scholarships
The IASLC and the Lung Cancer Foundation of America (LCFA) are proud to announce a Request for Application for the LCFA/IASLC Lori Monroe Scholarship in Translational Lung Cancer Research. The scholarship will fund two lung cancer research grants over two years. Each grant recipient will receive $200,000. The objective of this award is to support research that improves the care of individuals with lung cancers and to reduce the burden of these diseases.
The deadline to apply is June 30, 2016.
Scientific Advances in Lung Cancer 2015
The May 2016 issue of IASLC's Journal of Thoracic Oncology (JTO) features the inaugural publication of “Scientific Advances in Lung Cancer 2015." Summarizing the remarkable progress in lung cancer prevention, diagnosis, staging and treatment in 2015, "Scientific Advances in Lung Cancer 2015" draws on the work and knowledge of more than 34 multidisciplinary experts from around the globe, in different areas of lung cancer research and management.
This publication serves as another valuable educational resource, designed to keep busy practitioners, scientists and others interested in lung cancer up-to-date, with the primary focus being on non-small cell lung cancer (NSCLC).
The four major content categories that the publication covers are:
IASLC would like to thank the following authors for their contribution to this publication:
Anne S. Tsao, MD, Giorgio V. Scagliotti, MD, PhD, Paul A Bunn, Jr, MD, David P. Carbone, MD, PhD, Graham W. Warren MD, PhD, Chunxue Bai MD, PhD, Harry J. de Koning, MD, PhD, A. Uraujh Yousaf-Khan, MD, Annette McWilliams, MBBS, FRACP, Ming Sound Tsao, MD, FRCPC, Prasad S. Adusumilli, MD, FACS, FCCP, Ramón Rami-Porta, MD, Hisao Asamura, MD, Paul E. Van Schil, MD, PhD, Gail E. Darling, MD, FRCSC, FACS, Suresh S. Ramalingam, MD, Daniel R. Gomez, MD, Kenneth E. Rosenzweig, MD, Stefan Zimmermann, MD, Solange Peters, MD, PhD, Sai-Hong Ignatius Ou, MD PhD, Thanyanan Reungwetwattana, MD, MS, Pasi A. Jänne, MD, PhD, Tony S. Mok, MD, Heather A. Wakelee, MD, Robert Pirker, MD, Julien Mazières, MD, PhD, Julie R. Brahmer, MD, Yang Zhou, PhD MPH, Roy S. Herbst, MD, PhD, Vassiliki A. Papadimitrakopoulou, MD, Mary W. Redman, PhD, Murry W. Wynes, PhD, David R. Gandara, MD, Ronan J. Kelly, MD, MBA, Fred R. Hirsch MD, PhD, Harvey I. Pass, MD.
REMINDER: IASLC Newsletter Survey
Thank you to those who have responded to the survey we sent to all members in early April. We encourage those of you who have not filled it out to do so as soon as possible. The survey's goal is to solicit your feedback, and to ensure this monthly newsletter meets your needs. All respondents are automatically entered into a drawing to receive a free Apple iPad.
Please note that the survey link was sent to members through an individual email. Responses are kept anonymous unless you choose to include your contact details. If you have still not received the survey link and would like to participate, please contact email@example.com. The deadline is May 20, 2016.
Thank you for your participation in this project. We appreciate your support and look forward to reading your responses.
Royal Dutch Medical Association Tobacco Discouragement Policy
The Royal Dutch Medical Association has released its KNMG Tobacco Discouragement Policy, which lays out its position on tobacco use as part of a program on preventive and national health care. Commenting that, “Every day, doctors deal with patients who become ill or die as a consequence of smoking. Smoking is the leading preventable cause of illness and death in the Netherlands, and some twenty thousand people die each year as a result of smoking,” this policy represents one significant effort being made towards a smoke-free society.
As a service to our members, we post opportunities related to lung cancer and other thoracic malignancies on our website. This now includes academic career opportunities. Click here to review post-doctoral and other career opportunities submitted to IASLC. If you have an academic career opportunity, please email it to firstname.lastname@example.org.
We also post opportunities when we receive information from grantors. We currently have three funding opportunities posted:
These opportunities are available to applicants from all countries. Click here to learn more.
Social Media Corner: Connecting Members Around the Globe!
By Matthew Evison, UK Lung Cancer Pulmonologist, IASLC Communications Committee
Twitter has the power to connect people around the globe. I now find myself connected to patient advocates, global lung cancer awareness events and the international lung cancer community. Immediate updates from international conferences, key research published ahead of print and daily media stories help me stay current with lung cancer developments. The IASLC recognizes the potential of social media and embraces it.
We need to continue to find ways to connect IASLC members around the globe: to shape future collaborations and promote awareness campaigns by sharing knowledge and experience. To promote connections, IASLC members on Twitter can use a new hashtag: #IamIASLC. Twitter users can search via this hashtag and connect with other like-minded colleagues. Exciting research published? Valuable learning at a conference? Promoting awareness of lung cancer? Share it with the IASLC community.
I also want to highlight #LCSM (Lung Cancer Social Media) as a globally-used hashtag by the lung cancer community.
May 2016: The IASLC and the Journal of Thoracic Oncology (JTO) are pleased to present the Editor's Choice each month to highlight certain articles of interest. The selected articles will be made available to the public for a limited time upon printing. The articles below from the May issue of JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
The selections for this month deal exclusively with issues of lung cancer staging in the 8th edition of the lung cancer TNM classification. As the journal's readers are aware, the IASLC Lung Cancer Staging Committee embarked on revisions for the 8th edition of the TNM classification for lung cancer in 2009.
The IASLC Staging Project: Summary of Proposals for the Classification of Lung Cancers With Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification
The IASLC Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers From Metastatic Foci in Patients With Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
The IASLC Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules With Ground Glass or Lepidic Features or a Pneumonic-Type Involvement in the Forthcoming Eighth Edition of the TNM Classification
The IASLC Staging Project: Background Data and Proposals for the Classification of Lung Cancer With Separate Tumor Nodules in the Eighth Edition of the TNM Classification of Lung Cancer
This is a valiant effort and all four chapters should be read together for a better grasp of this complex subject matter.
The following articles have been selected from the JTO by the IASLC Communications Committee to be promoted to the media and the public with press releases that were released at the time of online publication (Published Ahead of Print). To read more IASLC Press Releases, please visit IASLC Research Articles. These press releases are also announced via social media, so please follow IASLC on Twitter, LinkedIn and Facebook to stay up to date on the latest scientific topics
Molecular analysis of a tumor biopsy from a proto-oncogene 1 receptor tyrosine kinase positive (ROS1+) patient with acquired crizotinib resistance revealed a novel mutation in the v-kit Hardy Zuckerman 4 feline sarcoma viral oncogene homolog receptor tyrosine kinase (KIT) that can potentially be targeted by KIT inhibitors.
April 11, 2016 | More
Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging, and treatment in 2015, IASLC announces the inaugural publication of “Scientific Advances in Lung Cancer 2015” in the May 2016 issue of the IASLC’s JTO.
April 28, 2016 | More
Updated 2016 Member Directory Now Online!
You can access the 2016 Member Directory online in two ways:
*New* Free Membership for Patients/Survivors
COMPLIMENTARY Fellows/Residents/Students/Trainees Membership – Group Program Registration
Welcome New IASLC Members through April 28, 2016 (listed by name, then country):
Update on Lung Cancer Awareness Month Strategy Project (LCAM2016)
If you would like more information about this project, please contact IASLC Director of Membership, Kristin Richeimer (Kristin.email@example.com or +1.720.325.2953).
IASLC WCLC 2016 Patient Advocacy Awards Announced – Open for Submission:
Applicants for the Advocacy Travel Award are required to submit a detailed application, a summary of expected outcomes for attending, and any other supporting documentation required for review by IASLC. The award is open to organizations that can show 501(c)(3) or a similar type of non-profit status, and to individuals not affiliated with an advocacy organization. Click here for more information.
Immunotherapy Profiled in Washington Post
Although researchers are a long way from fully understanding the therapy and why it works for some patients and not others, sharply higher survival rates among some immunotherapy patients are providing reasons for hope. Read the full article on the Washington Post.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
February 20 - 23 2019Santa Monica, California
April 3 - 5 2019New York, New York
April 10 - 13 2019Geneva, Switzerland